Evelo Biosciences

EVLO39

Penny Stock

$0.000.00%$0.00

Penny Stock

EVLO39

$0.00

0.00%$0.00

Penny Stock

Performance History

Key Stats
Open	$0.00
Prev. Close	$0.00
EPS	-15.64
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$1,898.00
PE Ratio	-

	LOW	HIGH
Day Range	0.00	0.00
52 Week Range	0.00	13.93

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-15.64

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Evelo Biosciences (EVLO)

Evelo Biosciences Inc (EVLO) is a biotechnology company focused on the development and commercialization of therapies for the treatment of a variety of diseases. The company's pipeline includes candidates targeting inflammatory diseases, immune oncology, and autoimmune disorders. With a strong emphasis on the microbiome as a key driver of disease, Evelo Biosciences is at the forefront of advancing novel therapies that leverage the body's own natural defense mechanisms.

The stock price history of Evelo Biosciences Inc has shown fluctuations over the years. Investors have closely followed the company's progress and prospects, resulting in both positive and negative movements in the stock price. It is important for investors to conduct thorough research and analysis before making any investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Balkrishan Gill Ph.D.
Headquarters: Cambridge
Employees: 66
Exchange: NASDAQ

Keep an eye on Evelo Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Evelo Biosciences 's (EVLO) price per share?

The current price per share for Evelo Biosciences (EVLO) is $0. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Evelo Biosciences (EVLO)?

For Evelo Biosciences (EVLO), the 52-week high is $13.93, which is 13.93M% from the current price. The 52-week low is $0, the current price is 0% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Evelo Biosciences (EVLO) a growth stock?

Evelo Biosciences (EVLO) has shown an average price growth of -6.03% over the past three years. It has received a score of -7 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Evelo Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Evelo Biosciences (EVLO) stock price performance year to date (YTD)?

As of the latest data, Evelo Biosciences (EVLO) has a year-to-date price change of -99.81%. Looking at a longer horizon, the five-year price change stands at -100%.

help

Is Evelo Biosciences (EVLO) a profitable company?

Evelo Biosciences (EVLO) has a net income of -$82.35M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$74.34M. Furthermore, the EBITDA is -$69.67M.

help

What is the market capitalization of Evelo Biosciences (EVLO)?

Evelo Biosciences (EVLO) has a market capitalization of $1.9K. The average daily trading volume is 9.49K, indicating the stock's liquidity and investor engagement.